Embryonic and posthatching treatments with sex steroids demasculinize the motivational aspects of crowing behavior in male Japanese quail.
Demasculinizing action of embryonic estrogen on crowing behavior in male Japanese quails was examined. Eggs were treated with either 20 microg of estradiol benzoate (EB) or vehicle on the 10th day of incubation. Chicks hatched from both groups of eggs were injected daily with either testosterone propionate (TP; 10 microg/g b.w.), 5alpha-dihydrotestosterone (DHT, a non-aromatizable androgen; 10 microg/g b.w.), or vehicle from 11 to 50 days after hatching, and during this period their calling behaviors were observed. Irrespective of embryonic treatments, all birds received posthatching treatment with either TP or DHT, but not with vehicle, emitted crows in place of distress calls in a stress (non-sexual) context of being isolated in a recording chamber. The posthatching TP, but not posthatching DHT, induced crowing in a sexual context (crowing in their home-cages) from much earlier age than posthatching vehicle in the birds received control embryonic treatment with vehicle. The same TP treatment, however, completely eliminated the crowing in a sexual context in the birds received EB during their embryonic life. In the birds treated with either posthatching DHT or posthatching vehicle, the crowing in a sexual context was only slightly decreased by embryonic EB treatment. These data suggest that posthatching estrogen, derived from testosterone aromatization, enhances the demasculinizing action of embryonic estrogen, and thus strongly reduces the sexual motivation for crowing behavior. This demasculinizing action, however, would not influence vocal control system which generates acoustic pattern of crowing in the presence of androgens allowing the birds to crow in a non-sexual context.
Hosokawa
Nami
N
Department of Materials and Life Sciences, Sophia University, Tokyo, Japan.
Chiba
Atsuhiko
A
D000704:Analysis of Variance; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002988:Cloaca / Q000187:drug effects / Q000254:growth & development; D003370:Coturnix / Q000196:embryology / Q000502:physiology*; D013196:Dihydrotestosterone / Q000494:pharmacology*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D008297:Male; D009929:Organ Size / Q000187:drug effects; D012726:Sexual Behavior, Animal / Q000187:drug effects*; D013315:Stress, Psychological; D013737:Testis / Q000187:drug effects / Q000254:growth & development; D043343:Testosterone Propionate / Q000494:pharmacology*; D014828:Vocalization, Animal / Q000502:physiology*
D013196:Dihydrotestosterone; C074283:estradiol 3-benzoate; D004958:Estradiol; D043343:Testosterone Propionate